yttrium radioisotopes has been researched along with Lymphoma in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (19.35) | 18.2507 |
| 2000's | 19 (61.29) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumitani, S; Matsuo, H; Saeki, Y; Sakurashita, H; Taogoshi, T; Yoshikawa, H | 1 |
| Muylle, K; Vanderlinden, B | 1 |
| Kao, YH | 1 |
| Bäck, TA; Booth, GC; Fisher, DR; Frayo, SL; Frost, SH; Gopal, AK; Green, DJ; Hylarides, MD; Lin, Y; Miller, BW; Orozco, JJ; Pagel, JM; Press, OW | 1 |
| Schmitz, N | 1 |
| Brechbiel, MW; Carrasquillo, JA; Garmestani, K; Goldman, CK; Paik, CH; Waldmann, TA; Yao, Z; Yu, S; Zhang, M | 1 |
| Gopal, AK; Winter, JN | 1 |
| Gabriel, M | 1 |
| Bron, D; de Wind, A; Delatte, P; Flamen, P; Meuleman, N; Muylle, K; Nguyen, J; Roelandts, M; Van der Stappen, A; Vanderlinden, B | 1 |
| de la Torre, A; Regueiro, CA; Romero, J; Valcárcel, FJ | 1 |
| Divgi, CR; Hamlin, PA; Larson, SM; Pandit-Taskar, N; Reyes, S | 1 |
| Boerman, OC; Corstens, FH; Frielink, C; Goldenberg, DM; Oyen, WJ; Postema, EJ; Raemaekers, JM | 1 |
| Hindorf, C; Lindén, O; Stenberg, L; Strand, SE; Tennvall, J | 1 |
| Imam, SK | 1 |
| Coleman, M; Furman, RR; Leonard, JP; Ruan, J | 1 |
| Dietlein, M; Engert, A; Eschner, W; Fischer, T; Pinkert, J; Schicha, H; Schnell, R; Schomäcker, K; Zimmermanns, B | 1 |
| Bradt, BM; Chan, K; DeNardo, GL; DeNardo, SJ; Tobin, E | 1 |
| Dreyling, M; Hiddemann, W; Illidge, T; Weigert, O | 1 |
| Cheung, MC; Haynes, AE; Imrie, K; Meyer, RM; Stevens, A | 1 |
| Tobinai, K | 1 |
| Altavilla, G; Arrigo, C; Baldari, S; Naro, C; Perniciaro, F; Pitini, V | 1 |
| Klener, P; Trnený, M | 1 |
| Chapuy, B; Hohloch, K; Trümper, L | 1 |
| Goldenberg, DM; Govindan, SV; Griffiths, GL; Hansen, HJ; Leung, SO; Losman, MJ | 1 |
| Beresford, BA; Häfeli, UO; Humm, JL; Macklis, RM; Sweeney, SM | 1 |
| Kuzel, TM; Rosen, ST | 1 |
| Beresford, BA; Humm, JL; Macklis, RM | 1 |
| Hahn, K | 1 |
| Hainsworth, JD | 1 |
| Amox, DG; Green, MR; Halpern, SE; Hupf, H; Miller, RA; Parker, BA; Royston, I; Simoni, JL; Starr, RJ; Vassos, AB | 1 |
| Adamas, GP; DeNardo, GL; DeNardo, SJ; Deshpande, SV; McCall, MK; Meares, CF; Moi, MK | 1 |
9 review(s) available for yttrium radioisotopes and Lymphoma
| Article | Year |
|---|---|
Radioimmunoconjugates in hematopoietic stem cell transplantation.
Topics: Disease-Free Survival; Dose-Response Relationship, Radiation; Hematopoietic Stem Cell Transplantation; Humans; Immunoconjugates; Iodine Radioisotopes; Lymphoma; Neoplasms; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Radionuclide therapy beyond radioiodine.
Topics: Bone Neoplasms; Gamma Rays; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphoma; Neoplasms; Neuroendocrine Tumors; Palliative Care; Radiation Protection; Radioimmunotherapy; Radioisotopes; Receptors, Somatostatin; Thyroid Neoplasms; Yttrium Radioisotopes | 2012 |
Molecular nuclear imaging: the radiopharmaceuticals (review).
Topics: Animals; Annexins; Antibodies, Monoclonal; Antigens; Apoptosis; Cysteine; Diagnostic Imaging; DNA; Fluorodeoxyglucose F18; Glycolysis; Humans; Indium Radioisotopes; Ligands; Lymphoma; Myocardial Infarction; Neoplasms; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2005 |
New developments in immunotherapy for non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Humans; Immunotherapy; Interleukin-2; Lymphoma; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Radioimmunotherapy; Rituximab; Yttrium Radioisotopes | 2005 |
Yttrium 90 ibritumomab tiuxetan in lymphoma.
Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Disease Progression; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Quality of Life; Radioimmunotherapy; Radiometry; Treatment Outcome; Yttrium Radioisotopes | 2006 |
[Ten years since the successful introduction of the first monoclonal antibody (rituximab) into the therapy of lymphomas].
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Humans; Lymphoma; Radioimmunotherapy; Rituximab; Yttrium Radioisotopes | 2007 |
Yttrium 90 ibritumomab tiuxetan (Zevalin): a new bullet in the fight against malignant lymphoma?
Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; Humans; Lymphoma; Models, Biological; Radioimmunotherapy; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Radioimmunotherapy of lymphoma.
Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Humans; Iodine Radioisotopes; Lymphoma; Radioimmunotherapy; Yttrium Radioisotopes | 1993 |
Monoclonal antibody therapy in lymphoid malignancies.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Clinical Trials as Topic; Humans; Immunoconjugates; Lymphoma; Rituximab; Yttrium Radioisotopes | 2000 |
1 trial(s) available for yttrium radioisotopes and Lymphoma
| Article | Year |
|---|---|
4. Antibody therapy for malignant lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Radioimmunotherapy; Rituximab; Yttrium Radioisotopes | 2007 |
21 other study(ies) available for yttrium radioisotopes and Lymphoma
| Article | Year |
|---|---|
Safety of
Topics: Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Asian People; Female; Humans; Japan; Leukopenia; Lymphoma; Male; Middle Aged; Neutropenia; Radiopharmaceuticals; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Reply to letter re: general theory of predictive dosimetry for yttrium-90 radioembolization to sites other than the liver.
Topics: Humans; Lymphoma; Male; Multimodal Imaging; Splenomegaly; Yttrium Radioisotopes | 2014 |
General theory of predictive dosimetry for yttrium-90 radioembolization to sites other than the liver.
Topics: Bronchial Arteries; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Multimodal Imaging; Splenomegaly; Yttrium Radioisotopes | 2014 |
Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.
Topics: Animals; Antigens, CD20; Beta Particles; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Humans; Immunoconjugates; Lutetium; Lymphoma; Mice; Mice, Nude; Radioimmunotherapy; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2015 |
Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Humans; Immunotoxins; Lymphoma; Radioimmunotherapy; Rituximab; Yttrium Radioisotopes | 2008 |
Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibody Specificity; Cell Line, Tumor; Daclizumab; Disease-Free Survival; Endocytosis; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Kaplan-Meier Estimate; Lymphoma; Maximum Tolerated Dose; Mice; Mice, Nude; Radioimmunotherapy; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2009 |
Radioembolization of the spleen: a revisited approach for the treatment of malignant lymphomatous splenomegaly.
Topics: Aged; Biopsy, Needle; Disease Progression; Embolization, Therapeutic; Fatal Outcome; Humans; Immunohistochemistry; Lymphoma; Male; Microspheres; Multimodal Imaging; Radiation Dosage; Radiopharmaceuticals; Spleen; Splenectomy; Splenomegaly; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Treatment of conjunctival lymphomas by beta-ray brachytherapy using a strontium-90-yttrium-90 applicator.
Topics: Adult; Aged; Brachytherapy; Conjunctival Neoplasms; Disease-Free Survival; Female; Humans; Lymphoma; Male; Middle Aged; Radiation Injuries; Retrospective Studies; Risk Factors; Strontium Radioisotopes; Treatment Outcome; Yttrium Radioisotopes | 2002 |
New strategies in radioimmunotherapy for lymphoma.
Topics: Antibodies, Monoclonal; Clinical Trials, Phase III as Topic; Contraindications; Humans; Iodine Radioisotopes; Lymphoma; Lymphoma, Non-Hodgkin; Radiometry; Yttrium Radioisotopes | 2003 |
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Cell Adhesion Molecules; Duodenum; Female; Femur; Humans; Iodine Radioisotopes; Kidney; Lectins; Liver; Lung; Lutetium; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Nude; Muscles; Neoplasm Transplantation; Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Sialic Acid Binding Ig-like Lectin 2; Spleen; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2003 |
Change in tumor-absorbed dose due to decrease in mass during fractionated radioimmunotherapy in lymphoma patients.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dose Fractionation, Radiation; Humans; Lymphoma; Models, Statistical; Radioimmunotherapy; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Time Factors; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2003 |
[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives].
Topics: Anemia; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Humans; Lymphoma; Neutropenia; Quality Control; Radiation Protection; Radioimmunotherapy; Radionuclide Imaging; Thrombocytopenia; Yttrium Radioisotopes | 2005 |
Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodies.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Combined Modality Therapy; Dose-Response Relationship, Immunologic; HLA-DR Antigens; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Mice; Microscopy, Fluorescence; Radioimmunotherapy; Radiopharmaceuticals; Time Factors; Treatment Outcome; Trypan Blue; Yttrium Radioisotopes | 2005 |
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphoma.
Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Humans; Lymphoma; Practice Guidelines as Topic; Radioimmunotherapy; Yttrium Radioisotopes | 2006 |
Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and Temozolomide.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction; Salvage Therapy; Survival Rate; Temozolomide; Yttrium Radioisotopes | 2007 |
Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
Topics: Animals; Antibodies, Neoplasm; Carcinoembryonic Antigen; Glycosylation; Immunoglobulin Fab Fragments; Immunoglobulin Light Chains; Indium Radioisotopes; Isotope Labeling; Lymphoma; Mice; Mice, Nude; Technetium; Yttrium Radioisotopes | 1995 |
Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.
Topics: Animals; Cell Line; Cell Survival; Culture Techniques; Dose-Response Relationship, Radiation; Female; Humans; Lactates; Lactic Acid; Lymphoma; Magnetics; Mice; Mice, Inbred C57BL; Microspheres; Neuroblastoma; Pentetic Acid; Polyesters; Polymers; Radionuclide Imaging; Skin Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 1995 |
Radiobiologic studies of low-dose-rate 90Y-lymphoma therapy.
Topics: Animals; Caffeine; Cell Cycle; Cell Survival; DNA Damage; Humans; Lymphoma; Mice; Radioimmunotherapy; Radionuclide Imaging; Radiotherapy Dosage; Tumor Cells, Cultured; Yttrium Radioisotopes | 1994 |
[Nuclear medicine--therapeutic advances into new dimensions?].
Topics: Animals; Glioma; Humans; Iodine Radioisotopes; Lymphoma; Neoplasms; Nuclear Medicine; Polycythemia Vera; Radiotherapy Dosage; Thyroid Neoplasms; Tumor Cells, Cultured; Yttrium Radioisotopes | 2000 |
Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody.
Topics: Adult; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; B-Lymphocytes; Female; Humans; Indium Radioisotopes; Lymphoma; Mice; Radionuclide Imaging; Yttrium Radioisotopes | 1990 |
Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancer.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Chelating Agents; Copper Radioisotopes; Female; Humans; Immunotherapy; Immunotoxins; Lymphoma; Mice; Yttrium Radioisotopes | 1990 |